1. Home
  2. CLMB vs EDIT Comparison

CLMB vs EDIT Comparison

Compare CLMB & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLMB

Climb Global Solutions Inc.

HOLD

Current Price

$26.72

Market Cap

387.6M

Sector

Technology

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.70

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMB
EDIT
Founded
1982
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
387.6M
432.8M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
CLMB
EDIT
Price
$26.72
$2.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$80.00
$5.30
AVG Volume (30 Days)
137.7K
2.0M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
0.60%
N/A
EPS Growth
14.29
37.50
EPS
0.18
N/A
Revenue
$652,517,000.00
$31,937,000.00
Revenue This Year
$7.82
N/A
Revenue Next Year
$5.83
N/A
P/E Ratio
$157.83
N/A
Revenue Growth
40.14
132.64
52 Week Low
$15.25
$1.66
52 Week High
$145.00
$4.54

Technical Indicators

Market Signals
Indicator
CLMB
EDIT
Relative Strength Index (RSI) 71.09 37.75
Support Level $24.09 $2.36
Resistance Level $112.00 $2.73
Average True Range (ATR) 1.18 0.17
MACD 0.24 -0.07
Stochastic Oscillator 91.53 10.53

Price Performance

Historical Comparison
CLMB
EDIT

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, United Kingdom, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: